http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73683e22857ea3c56b9dea95ca479580
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Norinder |
| name | Ulf Norinder |
| given-name | Ulf |
| organization-name | Department of Computer and Systems Sciences, Stockholm University, Kista, Sweden. Swedish Toxicology Sciences Research Center, SE-151 36 Södertälje, Sweden AstraZeneca Research and Development Södertälje, SE-151 85 Södertälje, Sweden Research and Development Laboratories, Astra Alab AB, S-151 85 Södertälje MTM Research Centre, School of Science and Technology, Örebro University, SE-70182 Örebro, Sweden Center of Pharmaceutical Informatics, Department of Pharmacy, Uppsala University, Uppsala Biomedical Center, P.O. Box 580, SE-751 23 Uppsala, Sweden, Department of Medicinal Chemistry, AstraZeneca Research and Development, SE-151 85 Södertälje, Sweden, and Department of Chemistry, Medicinal Chemistry, Göteborg University, SE-412 96 Göteborg, Sweden Swetox, Karolinska Institutet, Unit of Toxicology Sciences, Södertälje 15136, Sweden AstraZeneca R&D Södertälje, Sweden Center for Pharmaceutical Informatics, Department of Pharmacy, Uppsala University, Uppsala Biomedical Center, P.O. Box 580, SE-751 23 Uppsala, Sweden, Department of Medicinal Chemistry, AstraZeneca R&D, SE−151 85 Södertälje, Sweden, and Department of Chemistry, Medicinal Chemistry, Göteborg University, SE−412 96 Göteborg, Sweden Department of Computer and Systems Sciences, Stockholm University, Box 7003, 164 07 Kista, Sweden; MTM Research Centre, School of Science and Technology, Örebro University, 701 82 Örebro, Sweden; Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 75 124 Uppsala, Sweden Swetox; Karolinska Institutet; Unit of Toxicology Sciences; SE-151 36 Södertälje; Sweden Center of Pharmaceutical Informatics, Department of Pharmacy, Uppsala University, Uppsala Biomedical Center, P.O. Box 580, SE-751 23 Uppsala, Sweden, and Department of Medicinal Chemistry, AstraZeneca Research and Development, SE-151 85 Södertälje, Sweden Structural Chemistry, Biovitrum AB, SE-112 76 Stockholm, Sweden, Department of Medicinal Chemistry, Uppsala University, BMC, Box 574, SE-751 23, Uppsala, Sweden, Compumine AB, Österögatan 3, SE-164 40, Kista, Sweden, Department of Computer and Systems Sciences, Stockholm University and Royal Institute of Technology, Forum 100, SE-164 40 Kista, Sweden, and AstraZeneca R&D Södertälje, SE-151 85 Södertälje, Sweden Unit of Toxicology Sciences, Swetox, Karolinska Institutet, SE-15136 Södertälje, Sweden Pharmaceutical Screening and Informatics, Department of Pharmacy, Uppsala University, Biomedical Center, Post Office Box 580, SE-751 23 Uppsala, Sweden, Department of Medicinal Chemistry, AstraZeneca R&D Södertälje, SE-151 85 Södertälje, Sweden Department of Computer and Systems Sciences, Stockholm University, Kista, Sweden Pharmaceutical Screening and Informatics, Department of Pharmacy and Cancer Pharmacology and Informatics, Department of Medical Sciences, Uppsala University, Sweden, and AstraZeneca R&D, Mölndal, Lund, and Södertälje, Sweden AstraZeneca R&D Södertälje, Sweden; Department of Pharmacy, Uppsala University, Sweden Department of Computer and Systems Sciences, Stockholm University, Kista, Sweden. Unit of Toxicology Sciences, Swetox, Karolinska Institutet, Södertälje, Sweden. AstraZeneca Research and Development Södertälje, SE-151 85 Södertälje, Sweden; Department of Pharmacy, Uppsala University, SE-751 23 Uppsala, Sweden Swetox, Karolinska Institutet, Unit of Toxicology Sciences, Södertälje, Sweden; Department of Computer and Systems Sciences, Stockholm University, SE Kista, Sweden Swetox, Unit of Toxicology Sciences, Karolinska Institutet, Forskargatan 20, SE-151 36 Södertälje, Sweden; Department of Computer and Systems Sciences, Stockholm University, Box 7003, SE-164 07 Kista, Sweden Swedish Toxicology Sciences Research Center, Karolinska Institutet, Södertälje, Sweden Swetox, Karolinska Institutet, Unit of Toxicology Sciences, Forskargatan 20, SE-151 36 Södertälje, Sweden; Department of Computer and Systems Sciences, Stockholm University, Forum 100, SE-164 40 Kista, Sweden CNSP Innovative Medicines, AstraZeneca R&D Södertälje, Sweden Safety Assessment, AstraZeneca Research & Development, 43183 Mölndal, Sweden, and Medicinal Chemistry, AstraZeneca Research & Development 15185 Södertälje, Sweden Pharmaceutical Sciences R&D, Pharmacia Corporation, SE-112 87 Stockholm, Sweden, and AstraZeneca R&D Södertälje, SE-151 85 Södertälje, Sweden Swedish Toxicology Sciences Research Center; SE-151 36 Södertälje; Sweden; Dept. Computer and Systems Sciences; Stockholm Univ. H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark Department of Pharmaceutics, Uppsala Biomedical Center, Uppsala University, P.O. Box 580, SE-751 23 Uppsala, Sweden; Department of Medicinal Chemistry, AstraZeneca Research and Development, SE-151 85 Södertälje, Sweden; and Department of Medicinal Chemistry, Institute of Pharmacy, University of Tromsø, N-9037 Tromsø, Norway Department of Pharmacy, Uppsala University, 751 23 Uppsala, Sweden; AstraZeneca R&D, 151 85 Södertälje, Sweden Swetox, Karolinska Institutet, Unit of Toxicology Sciences, Forskargatan 20, SE-151 36 Södertälje, Sweden; Department of Computer and Systems Sciences, Stockholm University, Box 7003, SE-164 07 Kista, Sweden H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby, Denmark Department of Computer and Systems Sciences, Stockholm University, SE-16407 Kista, Sweden; Department of Pharmaceutical Biosciences, Uppsala University, SE-75124 Uppsala, Sweden; MTM Research Centre, School of Science and Technology, Örebro University, SE-70182 Örebro, Sweden |
Incoming Links
Total number of triples: 124.